Skip to main content
. 2020 Dec 29;201:106451. doi: 10.1016/j.clineuro.2020.106451

Table 2.

Tests performed after SARS-CoV-2 infection.

Patient 1 2 3 4
EDSS 4.0 3.5 4.5 4.5
Lymphocyte count [103/μl] (N: 1−3.3) 0.82 1.47 2.25 2.82
Neutrophil count [103/μl] (N: 1.6−6) 4.58 4.18 6.39 3.08
WBC [103/μl] (N: 4−10.5) 6.33 6.22 10.08 5.42
Monocyte count [103/μl] (N: 0.15−0.6) 0.55 0.46 0.7 0.33
Eosinophil count [103/μl] (N: 0.2−0.5) 0.26 0.08 0.1 0.24
Basophil count [103/μl] (N: 0.01−0.1) 0.01 0.01 0.01 0.02
HCT [%] (N: 37−47) 38.9 37.6 37.1 40.7
RBC [103/μl] (N: 4.2−5.4) 4.42 4.46 4.39 4.54
Hb [g/dL] (N: 12.5−16] 13.2 12.5 12.4 14.3
MCV [fL] (N: 78−100) 88 84.3 84.5 89.6
MCH [pg] (N: 27−31) 29.9 28 28.2 31.5
MCHC [g/dL] (N: 32−36) 33.9 33.2 33.4 35.1
RDW-CV [%] (N: 11.5−14.5) 13 12.9 13.3 12.3
RDW-SD [fL] 42.1 39 41.1
PLT [103/μl] (N: 150−450) 244 250 356 229
MPV [fL] (N: 6−9.5) 10.4 11.3 10 10.6
PDW [fL] (N: 9.8−16.2) 11.6 13.5 10.8
P-LCR [%] (N: 19.1−47) 27 35.6 24.3 29.2
PCT [%] (N: 0.15−0.5) 0.25 0.28 0.35
CRP [mg/L] (N: 0−5) 1.38 9.01
IG [103/μl] (N: 0−0.015) 0.01 0.02 0.03
NRBC [103/μl] (N: 0−0.03) 0 0 0
MICROR [%] (N: 0.14−5.79) 1.7 3.4 2.9
MACROR [%] (N: 3.3–5.56) 3.5 3.9 3.9
ALT [U/L] (N: 0−41) 14.8 24.1 15 19
AST [U/l] (N: 0−40) 18.4 21.5 13.9 16
Total bilirubin [μmol/L] (N: 5−21) <2.5 8.9
Direct bilirubin [μmol/L] (N: 0−3.4) 4.7 3.2
Creatine kinase [U/L] (N: 10−200) 74 77
Serum creatinine [μmol/L] (N: 44−80) 53 50 55 66
GFR [ml/min/1.73 m2] 125.73 80
Blood sodium [mmol/L] (N: 136−146) 139
Blood potassium [mmol/L] (N: 3.5−5) 4.3
TSH [μIU/mL] (N: 0.27−4.2) 2.54 0.839 1.160
General urine test
(only abnormal results)
No abnormal results pH = 5; 6−8 leukocytes per high-power field; 2−4 erythrocytes per high-power field
Head MRI with contrast Number and size of demyelination lesions with an image similar to the previous examination, without activity signs Number and size of demyelination lesions with an image similar to the previous examination, without activity signs Number and size of demyelination lesions with an image similar to the previous examination, without activity signs Number and size of demyelination lesions with an image similar to the previous examination, without activity signs
VEP Abnormal Abnormal Abnormal Abnormal
BAEP Normal Normal normal Normal
NCS Normal Normal Normal normal
EEG Record with focal lesions bilaterally in the parasagittal region Normal record Normal record Record with focal lesions in the left frontotemporal region
CDD of extracranial vessels Normal Normal Normal Normal
Psychological test Increased anxiety rate Increased anxiety rate Normal emotional state Increased anxiety rate

EDSS – Expanded Disability Status Scale; N – normal result; ; WBC – white blood cells count; HCT – haematocrit; RBC – red blood cells count; Hb – haemoglobin; MCV – mean corpuscular volume; MCH – mean corpuscular haemoglobin; MCHC – mean corpuscular haemoglobin concentration; PLT – platelets count; MPV – mean platelet volume; PDW – platelet distribution width; P-LCR – platelet large cell ratio; PCT – procalcitonin; CRP – C-reactive protein; IG – immature granulocyte count; NRBC – nucleated red blood cells; MICROR – microcytes (micro red blood cells); MACROR – macrocytes (macro red blood cells); ALT – alanine transaminase; AST – aspartate transaminase; LDH - Lactate dehydrogenase; TSH – thyroid-stimulating hormone; MRI – magnetic resonance imaging; VEP – visual evoked potential; BAEP – brainstem auditory evoked potential; NCS – nerve conduction study; EEG – electroencephalography; CDD – Color-Coded Duplex Doppler. Deviations from the normal results are bold.